Novartis AG

Organization

Basel, CH

Ticker Symbols

NYSE:NVS

PHARMACEUTICAL PREPARATIONS
Business Address
LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
Mailing Address
LICHTSTRASSE 35 BASEL V8 CH 4056
State Location
V8
State of Incorporation
V8

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for...
- Patent number 12,257,243
- Issue date Mar 25, 2025
- Novartis AG
- James Paul Lajiness
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid support
- Patent number 12,258,680
- Issue date Mar 25, 2025
- Novartis AG
- Frederic Berst
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Antibody molecules to LAG-3 and uses thereof
- Patent number 12,252,535
- Issue date Mar 18, 2025
- Novartis AG
- Frédéric Triebel
- G01 - MEASURING TESTING
Information Patent Grant
Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...
- Patent number 12,252,478
- Issue date Mar 18, 2025
- Novartis AG
- Stephanie Kay Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...
- Patent number 12,252,479
- Issue date Mar 18, 2025
- Novartis AG
- Stephanie Kay Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyridine derivatives and uses thereof
- Patent number 12,252,482
- Issue date Mar 18, 2025
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhaler
- Patent number D1067421
- Issue date Mar 18, 2025
- Sandoz AG
- Tim Evans
- D24 - Medical and laboratory equipment
Information Patent Grant
Methods for improving the efficacy and expansion of immune cells
- Patent number 12,240,884
- Issue date Mar 4, 2025
- Novartis AG
- Felipe Bedoya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and compositions for inhibiting the activity of HIF2-alph...
- Patent number 12,226,405
- Issue date Feb 18, 2025
- Novartis AG
- Robin Alec Fairhurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cell-based assay for measuring drug product potency
- Patent number 12,228,571
- Issue date Feb 18, 2025
- Novartis AG
- Brian Kaspar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD19 binding molecules and uses thereof
- Patent number 12,221,481
- Issue date Feb 11, 2025
- Novartis AG
- Brian Granda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-BCMA chimeric antigen rece...
- Patent number 12,214,037
- Issue date Feb 4, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarker predictive of responsiveness to alpha 7 nicotinic acetylc...
- Patent number 12,215,387
- Issue date Feb 4, 2025
- Novartis AG
- Dominik Feuerbach
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (P...
- Patent number 12,209,144
- Issue date Jan 28, 2025
- Novartis AG
- Alec Nathanson Flyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors for treatment of uveal melanoma
- Patent number 12,208,097
- Issue date Jan 28, 2025
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)i...
- Patent number 12,208,101
- Issue date Jan 28, 2025
- Novartis AG
- Elisabete Goncalves
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inducing chondrogenesis
- Patent number 12,209,096
- Issue date Jan 28, 2025
- Novartis AG
- Ha-Soon Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 12,209,098
- Issue date Jan 28, 2025
- Novartis AG
- Christine Hiu-Tung Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of mavoglurant in the reduction of alcohol use or in preventing...
- Patent number 12,201,612
- Issue date Jan 21, 2025
- Novartis AG
- Ricardo Carl Elciario Dolmetsch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug delivery device
- Patent number D1057937
- Issue date Jan 14, 2025
- Sandoz AG
- Leon Rizner
- D24 - Medical and laboratory equipment
Information Patent Grant
Injection device and injection solution transferring system
- Patent number 12,194,278
- Issue date Jan 14, 2025
- Novartis AG
- Nicholas Lee Hawson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...
- Patent number 12,187,703
- Issue date Jan 7, 2025
- Novartis AG
- Cornelius Stephen Harlacher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...
- Patent number 12,186,278
- Issue date Jan 7, 2025
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CCR7 antibody drug conjugates
- Patent number 12,180,291
- Issue date Dec 31, 2024
- Novartis AG
- Steven Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyridine derivatives and uses thereof
- Patent number 12,172,984
- Issue date Dec 24, 2024
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates for ablating hematopoietic stem cells
- Patent number 12,171,839
- Issue date Dec 24, 2024
- Novartis AG
- Anthony Edward Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Means and method for producing and purifying viral vectors
- Patent number 12,168,777
- Issue date Dec 17, 2024
- Novartis AG
- Brian K. Kaspar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 12,161,624
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 12,162,890
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITO...
- Publication number 20250115572
- Publication date Apr 10, 2025
- Novartis AG
- Christopher M. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20250109401
- Publication date Apr 3, 2025
- Novartis AG
- Jennifer BROGDON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAP...
- Publication number 20250108092
- Publication date Apr 3, 2025
- Novartis AG
- Barbara K. Felber
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
RIBOCICLIB PHARMACEUTICAL COMPOSITIONS
- Publication number 20250108053
- Publication date Apr 3, 2025
- Novartis AG
- Alpakumari CHAVDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING CANCER
- Publication number 20250099634
- Publication date Mar 27, 2025
- Novartis AG
- Per Ernst-Uno Broberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS TO TREAT CANCER
- Publication number 20250101435
- Publication date Mar 27, 2025
- Novartis AG
- Eric BILLY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA
- Publication number 20250099465
- Publication date Mar 27, 2025
- Novartis AG
- Souvik BHATTACHARYA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR XI ANTIBODIES AND METHODS OF USE
- Publication number 20250101130
- Publication date Mar 27, 2025
- Novartis AG
- Maximilian AIGNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-C...
- Publication number 20250101006
- Publication date Mar 27, 2025
- Novartis AG
- Markus BAENZIGER
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED...
- Publication number 20250092016
- Publication date Mar 20, 2025
- Novartis AG
- Denghui BAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TLR7/8-ANTAGONIST FOR TREATING SJÖGREN'S SYNDROME OR MIXED CONNECTI...
- Publication number 20250090538
- Publication date Mar 20, 2025
- Novartis AG
- Alexandre AVRAMEAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ribociclib Tablet
- Publication number 20250090531
- Publication date Mar 20, 2025
- Novartis AG
- Rui Costa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS
- Publication number 20250090491
- Publication date Mar 20, 2025
- Novartis AG
- Johan NEYTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
- Publication number 20250090699
- Publication date Mar 20, 2025
- Novartis AG
- Salvatore BONGARZONE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...
- Publication number 20250092042
- Publication date Mar 20, 2025
- Novartis AG
- Mallesh BUSHABOINA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK
- Publication number 20250092036
- Publication date Mar 20, 2025
- Novartis AG
- Erich W. BAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIGITAL SOLUTIONS FOR DIFFERENTIATING ASTHMA FROM COPD
- Publication number 20250087354
- Publication date Mar 13, 2025
- Novartis AG
- Paul Mastoridis
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20250084071
- Publication date Mar 13, 2025
- Novartis Pharma AG
- Shankar Venkatraman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...
- Publication number 20250082718
- Publication date Mar 13, 2025
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTH...
- Publication number 20250082611
- Publication date Mar 13, 2025
- Novartis AG
- Laura COLEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOSUPPRESSANT FORMULATIONS
- Publication number 20250084034
- Publication date Mar 13, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOSUPPRESSANT FORMULATION
- Publication number 20250073203
- Publication date Mar 6, 2025
- Novartis AG
- Philippe Michel Rene Bouillot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
- Publication number 20250066479
- Publication date Feb 27, 2025
- Novartis AG
- Gordon James Freeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20250066462
- Publication date Feb 27, 2025
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME
- Publication number 20250066813
- Publication date Feb 27, 2025
- Novartis AG
- Joseph BALLEYDIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING...
- Publication number 20250066466
- Publication date Feb 27, 2025
- Novartis AG
- Christian MANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20250064964
- Publication date Feb 27, 2025
- Novartis AG
- Anthony Edward BOITANO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydro-Pyrido-Pyrimidine Derivatives
- Publication number 20250059181
- Publication date Feb 20, 2025
- Novartis AG
- Nigel Graham Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYOMAVIRUS NEUTRALIZING ANTIBODIES
- Publication number 20250051423
- Publication date Feb 13, 2025
- Novartis AG
- Johanna ABEND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS
- Publication number 20250051345
- Publication date Feb 13, 2025
- Novartis AG
- Simon Krautwald
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
99114521 - ZOLGENSMA INTRATHECAL
- Serial number 99114521
- Filing date Apr 1, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99109506
- Serial number 99109506
- Filing date Mar 28, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419841 - ENGIVYV
- Serial number 79419841
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420337 - OFIVAYO
- Serial number 79420337
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420338 - ORZELTYVE
- Serial number 79420338
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420330 - VISISURE
- Serial number 79420330
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419842 - EINGEFYR
- Serial number 79419842
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420341 - FAKTIBO
- Serial number 79420341
- Filing date Feb 12, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419843 - CREYTIVBI
- Serial number 79419843
- Filing date Feb 11, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420339 - CIZEPNUE
- Serial number 79420339
- Filing date Feb 5, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420340 - ARIVDEY
- Serial number 79420340
- Filing date Feb 5, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419170 - AVIBTONZ
- Serial number 79419170
- Filing date Feb 5, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419172 - BECRENZI
- Serial number 79419172
- Filing date Feb 5, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79419169 - BQURB
- Serial number 79419169
- Filing date Feb 5, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420231 - KEPGAZO
- Serial number 79420231
- Filing date Jan 28, 2025
- Sandoz AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420232 - PASVILDA
- Serial number 79420232
- Filing date Jan 28, 2025
- Sandoz AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420233 - JUMABYR
- Serial number 79420233
- Filing date Jan 28, 2025
- Sandoz AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420622 - VONDIREQ
- Serial number 79420622
- Filing date Jan 24, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99016086
- Serial number 99016086
- Filing date Jan 23, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79420626 - ROLTRIO
- Serial number 79420626
- Filing date Jan 23, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99016129
- Serial number 99016129
- Filing date Jan 23, 2025
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98959583 - ORDER360
- Serial number 98959583
- Filing date Jan 14, 2025
- NOVARTIS AG
- 35 - Advertising
Information Trademark
98912297
- Serial number 98912297
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98912317
- Serial number 98912317
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79413172 - ITELPREO
- Serial number 79413172
- Filing date Nov 20, 2024
- NOVARTIS AG
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
79416191 - NOVARTIS RLT CARE
- Serial number 79416191
- Filing date Nov 6, 2024
- NOVARTIS AG
- 35 - Advertising
Information Trademark
79415080 - NOVARTIS RLT CARE
- Serial number 79415080
- Filing date Nov 6, 2024
- NOVARTIS AG
- 35 - Advertising
Information Trademark
79412901 - EDOMIGE
- Serial number 79412901
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79412902 - IGENTZA
- Serial number 79412902
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79412900 - ATLANYS
- Serial number 79412900
- Filing date Nov 1, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations

Novartis AG

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for...

Solid support

Antibody molecules to LAG-3 and uses thereof

Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...

Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-...

Pyrazolopyridine derivatives and uses thereof

Inhaler

Methods for improving the efficacy and expansion of immune cells

Compounds and compositions for inhibiting the activity of HIF2-alph...

Cell-based assay for measuring drug product potency

CD19 binding molecules and uses thereof

Treatment of cancer using humanized anti-BCMA chimeric antigen rece...

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylc...

Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (P...

Protein kinase C inhibitors for treatment of uveal melanoma

Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)i...

Compounds and compositions for inducing chondrogenesis

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

Use of mavoglurant in the reduction of alcohol use or in preventing...

Drug delivery device

Injection device and injection solution transferring system

Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-...

Mesothelin chimeric antigen receptor (CAR) and antibody against PD-...

Anti-CCR7 antibody drug conjugates

Pyrazolopyridine derivatives and uses thereof

Antibody drug conjugates for ablating hematopoietic stem cells

Means and method for producing and purifying viral vectors

NLRP3 inflammasome inhibitors

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Heteroaromatic NMDA receptor modulators and uses thereof

Patents Applicationslast 30 patents

SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITO...

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAP...

RIBOCICLIB PHARMACEUTICAL COMPOSITIONS

METHOD OF TREATING CANCER

COMPOSITIONS AND METHODS TO TREAT CANCER

REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA

FACTOR XI ANTIBODIES AND METHODS OF USE

PROCESS FOR THE SYNTHESIS OF PYRAZOLYL DERIVATIVES USEFUL AS ANTI-C...

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED...

TLR7/8-ANTAGONIST FOR TREATING SJÖGREN'S SYNDROME OR MIXED CONNECTI...

Ribociclib Tablet

ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS

FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTI...

COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK

DIGITAL SOLUTIONS FOR DIFFERENTIATING ASTHMA FROM COPD

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...

DOSING REGIMEN FOR AN NLRP3 INHIBITOR IN THE TREATMENT OF OSTEOARTH...

IMMUNOSUPPRESSANT FORMULATIONS

IMMUNOSUPPRESSANT FORMULATION

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME

METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING...

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

Tetrahydro-Pyrido-Pyrimidine Derivatives

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

PYRIDINE-3-CARBOXYLATE COMPOUNDS AS CAV1.2 ACTIVATORS

Trademarklast 30 trademarks

99114521 - ZOLGENSMA INTRATHECAL

99109506

79419841 - ENGIVYV

79420337 - OFIVAYO

79420338 - ORZELTYVE

79420330 - VISISURE

79419842 - EINGEFYR

79420341 - FAKTIBO

79419843 - CREYTIVBI

79420339 - CIZEPNUE